International Nosocomial Infection Control Consortium report, data summary of 50 countries for 2010-2015: Device-associated module.
Víctor Daniel Rosenthal,Hail M Al-Abdely,Amani Ali El-Kholy,Safa A Aziz AlKhawaja,Hakan Leblebicioglu,Yatin Mehta,Vineya Rai,Nguyen Viet Hung,Souha Sami Kanj,Mona Foda Salama,Estuardo Salgado-Yepez,Naheed Elahi,Rayo Morfin Otero,Anucha Apisarnthanarak,Braulio Matias De Carvalho,Bat Erdene Ider,Dale Fisher,Maria Carmen S G Buenaflor,Michael M Petrov,Ana Marcela Quesada-Mora,Farid Zand,Vaidotas Gurskis,Tanja Anguseva,Aamer Ikram,Daisy Aguilar de Moros,Wieslawa Duszynska,Nepomuceno Mejia,Florin George Horhat,Vladislav Belskiy,Vesna Mioljevic,Gabriela Di Silvestre,Katarina Furova,Gloria Y Ramos-Ortiz,May Osman Gamar Elanbya,Hindra Irawan Satari,Umesh Gupta,Tarek Dendane,Lul Raka,Humberto Guanche-Garcell,Bijie Hu,Denis Padgett,Kushlani Jayatilleke,Najla Ben Jaballah,Eleni Apostolopoulou,Walter Enrique Prudencio Leon,Alejandra Sepulveda-Chavez,Hector Miguel Telechea,Andrew Trotter,Carlos Alvarez-Moreno,Luis Kushner-Davalos
DOI: https://doi.org/10.1016/j.ajic.2016.08.007
IF: 4.303
2016-01-01
American Journal of Infection Control
Abstract:BACKGROUND:We report the results of International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2010-December 2015 in 703 intensive care units (ICUs) in Latin America, Europe, Eastern Mediterranean, Southeast Asia, and Western Pacific.
METHODS:During the 6-year study period, using Centers for Disease Control and Prevention National Healthcare Safety Network (CDC-NHSN) definitions for device-associated health care-associated infection (DA-HAI), we collected prospective data from 861,284 patients hospitalized in INICC hospital ICUs for an aggregate of 3,506,562 days.
RESULTS:Although device use in INICC ICUs was similar to that reported from CDC-NHSN ICUs, DA-HAI rates were higher in the INICC ICUs: in the INICC medical-surgical ICUs, the pooled rate of central line-associated bloodstream infection, 4.1 per 1,000 central line-days, was nearly 5-fold higher than the 0.8 per 1,000 central line-days reported from comparable US ICUs, the overall rate of ventilator-associated pneumonia was also higher, 13.1 versus 0.9 per 1,000 ventilator-days, as was the rate of catheter-associated urinary tract infection, 5.07 versus 1.7 per 1,000 catheter-days. From blood cultures samples, frequencies of resistance of Pseudomonas isolates to amikacin (29.87% vs 10%) and to imipenem (44.3% vs 26.1%), and of Klebsiella pneumoniae isolates to ceftazidime (73.2% vs 28.8%) and to imipenem (43.27% vs 12.8%) were also higher in the INICC ICUs compared with CDC-NHSN ICUs.
CONCLUSIONS:Although DA-HAIs in INICC ICU patients continue to be higher than the rates reported in CDC-NSHN ICUs representing the developed world, we have observed a significant trend toward the reduction of DA-HAI rates in INICC ICUs as shown in each international report. It is INICC's main goal to continue facilitating education, training, and basic and cost-effective tools and resources, such as standardized forms and an online platform, to tackle this problem effectively and systematically.